U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07546682) titled 'Propel Drug-Eluting Sinus Implant Family IBUKI Cohort' on April 16.

Brief Summary: To confirm clinical safety and performance for the PROPEL family of products when used according to IFUs and standard of care in Japan.

Study Start Date: April, 2026

Study Type: OBSERVATIONAL

Condition: Chronic Rhinosinusitis (CRS)

Intervention: OTHER: None, observational standard of care study

None, observational standard of care study

Recruitment Status: RECRUITING

Sponsor: Medtronic

Disclaimer: Curated by HT Syndication....